Related Experiment Video
Updated: Nov 7, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
ISI-3: evaluation of a brief screening tool for insomnia
Manu Thakral1, Michael Von Korff2, Susan M McCurry3
1College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA; Department of Child, Family, and Population Health Nursing, University of Washington School of Nursing, Seattle, WA, USA.
The Insomnia Severity Index-3 (ISI-3) effectively screens older adults for insomnia. This short tool, derived from the 7-item ISI, accurately identifies clinically significant sleep issues in primary care settings.
Area of Science:
- Gerontology
- Sleep Medicine
- Primary Care Research
Background:
- Insomnia is a prevalent sleep disorder in older adults, impacting overall health and quality of life.
- Accurate and efficient screening tools are crucial for timely diagnosis and intervention in primary care settings.
- The 7-item Insomnia Severity Index (ISI) is a validated measure, but shorter versions may improve usability.
Purpose of the Study:
- To evaluate the performance of the Insomnia Severity Index-3 (ISI-3) as a brief screening tool for clinically significant insomnia.
- To determine the diagnostic accuracy and optimal cut-points of the ISI-3 in an older primary care population.
- To assess the ISI-3's ability to identify individuals requiring further evaluation for insomnia.
Main Methods:
- Secondary analysis of data from two National Institute on Aging clinical trials involving individuals aged ≥60 years with osteoarthritis.
- Development of the ISI-3 using items from the 7-item ISI with the highest item-total correlations in Sample 1 (n=3197).
- Evaluation of ISI-3 diagnostic accuracy (sensitivity, specificity, AUC) against the 7-item ISI (score ≥15 as criterion) in Sample 1 and Sample 2 (n=247).
Main Results:
- The ISI-3, comprising sleep dissatisfaction, sleep interference with daily functioning, and worry about sleep problems, demonstrated high discriminant validity (AUC = 0.97-0.98).
- An ISI-3 score of ≥7 maximized sensitivity (0.94-0.97) and specificity (0.88-0.91), showing high agreement (89.1-91.5%).
- The selected items showed strong item-total correlations (r=0.78-0.81).
Conclusions:
- The ISI-3 serves as an effective and concise screening tool for insomnia in older adults within primary care.
- The ISI-3 can reliably identify individuals who may benefit from a more comprehensive insomnia assessment.
- Further validation in diverse community and clinical populations is recommended to broaden the applicability of the ISI-3.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Blind Procedures

